BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,056 filers reported holding BAXTER INTL INC in Q1 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $69,472 | +19.8% | 1,797 | +17.0% | 0.00% | 0.0% |
| Q3 2023 | $57,969 | -38.3% | 1,536 | -25.5% | 0.00% | -33.3% |
| Q2 2023 | $93,990 | +69.3% | 2,063 | +50.7% | 0.00% | +50.0% |
| Q1 2023 | $55,527 | +95636.2% | 1,369 | +20.0% | 0.00% | 0.0% |
| Q4 2022 | $58 | -99.9% | 1,141 | +7.5% | 0.00% | -33.3% |
| Q3 2022 | $57,000 | -6.6% | 1,061 | +11.1% | 0.00% | 0.0% |
| Q2 2022 | $61,000 | -3.2% | 955 | +17.2% | 0.00% | +50.0% |
| Q1 2022 | $63,000 | -1.6% | 815 | +9.0% | 0.00% | 0.0% |
| Q4 2021 | $64,000 | 0.0% | 748 | -5.3% | 0.00% | -33.3% |
| Q3 2021 | $64,000 | +8.5% | 790 | +7.3% | 0.00% | 0.0% |
| Q2 2021 | $59,000 | +9.3% | 736 | +15.7% | 0.00% | 0.0% |
| Q1 2021 | $54,000 | -10.0% | 636 | -14.7% | 0.00% | 0.0% |
| Q4 2020 | $60,000 | 0.0% | 746 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $60,000 | -6.2% | 746 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $64,000 | +4.9% | 746 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $61,000 | -86.9% | 746 | -86.6% | 0.01% | -82.8% |
| Q4 2019 | $464,000 | -4.5% | 5,551 | 0.0% | 0.03% | -12.1% |
| Q3 2019 | $486,000 | +279.7% | 5,551 | +255.8% | 0.03% | +266.7% |
| Q2 2019 | $128,000 | -99.8% | 1,560 | +93.5% | 0.01% | +80.0% |
| Q1 2019 | $65,536,000 | -1.6% | 806 | -20.4% | 0.01% | -16.7% |
| Q4 2018 | $66,610,000 | -54.8% | 1,012 | -47.1% | 0.01% | -45.5% |
| Q3 2018 | $147,473,000 | +1.5% | 1,913 | -2.7% | 0.01% | -8.3% |
| Q2 2018 | $145,243,000 | +16.7% | 1,967 | +2.8% | 0.01% | +20.0% |
| Q1 2018 | $124,422,000 | -4.4% | 1,913 | -5.0% | 0.01% | -9.1% |
| Q4 2017 | $130,120,000 | +314.7% | 2,013 | +302.6% | 0.01% | +266.7% |
| Q3 2017 | $31,375,000 | -13.8% | 500 | -16.8% | 0.00% | 0.0% |
| Q2 2017 | $36,385,000 | +16.7% | 601 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $31,168,000 | +0.3% | 601 | -14.3% | 0.00% | -25.0% |
| Q4 2016 | $31,082,000 | +37.5% | 701 | +40.2% | 0.00% | +33.3% |
| Q2 2016 | $22,610,000 | +10.1% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $20,540,000 | -33.0% | 500 | -37.8% | 0.00% | -25.0% |
| Q4 2015 | $30,673,000 | -28.5% | 804 | +34.4% | 0.00% | -55.6% |
| Q3 2015 | $42,919,000 | +18.7% | 598 | +19.6% | 0.01% | +12.5% |
| Q2 2015 | $36,150,000 | -21.2% | 500 | -25.4% | 0.01% | 0.0% |
| Q1 2015 | $45,895,000 | -10.5% | 670 | -4.3% | 0.01% | -52.9% |
| Q4 2014 | $51,303,000 | +19.5% | 700 | +17.1% | 0.02% | +88.9% |
| Q3 2014 | $42,918,000 | +18.7% | 598 | +19.6% | 0.01% | -35.7% |
| Q2 2014 | $36,150,000 | -1.7% | 500 | 0.0% | 0.01% | -36.4% |
| Q1 2014 | $36,790,000 | +5.8% | 500 | 0.0% | 0.02% | -31.2% |
| Q4 2013 | $34,775,000 | – | 500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |